Stocktoria
Inogen Inc INGN
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2014-02-14
Inogen Inc financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $348.7M | $335.7M | $315.7M | $377.2M | $358.0M |
| Gross profit | $154.3M | $154.7M | $126.7M | $153.5M | $176.5M |
| R&D expense | $19.4M | $21.6M | $20.8M | $21.9M | $16.6M |
| Operating income | -$30.2M | -$42.5M | -$109.4M | -$85.2M | $9.2M |
| Income tax | -$632,000 | -$588,000 | $105,000 | $504,000 | $15.0M |
| Net income | -$22.7M | -$35.9M | -$102.4M | -$83.8M | -$6.3M |
| EPS (diluted) | $-0.86 | $-1.52 | $-4.42 | $-3.67 | $-0.28 |
| Operating cash flow | -$11.2M | $5.9M | -$3.2M | -$37.5M | $23.6M |
| Free cash flow | -$13.7M | $2.6M | -$8.5M | -$40.9M | $18.2M |
| Cash & equivalents | $103.7M | $113.8M | $125.5M | $187.0M | $235.5M |
| Inventory | $26.0M | $24.8M | $21.8M | $34.1M | $31.9M |
| Total assets | $298.6M | $296.2M | $326.2M | $405.0M | $489.5M |
| Total liabilities | $106.4M | $122.3M | $121.4M | $107.6M | $119.3M |
| Shareholders' equity | $192.2M | $173.9M | $204.8M | $297.4M | $370.2M |
Source: SEC EDGAR filings · CIK 0001294133 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.